Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when NeuroPace Inc publishes a filing, an earnings call transcript or a press release.

Get NPCE alerts

About Joel Becker

Joel Becker is recorded as CEO and Board Member at NeuroPace Inc (NPCE). The newest filing on record that lists Joel Becker as CEO and Board Member at NeuroPace Inc (NPCE) is dated April 21, 2026. NeuroPace Inc reported in an 8-K filed June 28, 2023 that Joel Becker was appointed member of the Board, effective July 10, 2023. NeuroPace Inc reported in an 8-K filed June 28, 2023 that Joel Becker was appointed Chief Executive Officer, effective July 10, 2023. The proxy statement of NeuroPace Inc reports total compensation of $2,408,566 for Joel Becker in fiscal 2025, including a base salary of $567,567. Disclosed compensation is on record for 3 fiscal years. Joel Becker has spoken on 13 earnings calls and 2 other investor events across 1 company, most recently for NeuroPace Inc on August 11, 2026. NeuroPace Inc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at NeuroPace Inc includes Patrick F. Williams (CFO), Dr. Uri Geiger (Board Member), Lisa Andrade (Board Member) and 1 other.

“On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.”
NeuroPace Inc Form 8-K, filed June 28, 2023 · Read the filing
“On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.”
NeuroPace Inc Form 8-K, filed June 28, 2023 · Read the filing

Joel Becker on recent calls

“After that, Patrick will walk through our financial results and updated outlook before we open the line for questions. To start, our second quarter performance reflects continued momentum in the core R&S business and disciplined execution across the organization.”
CEO, Earnings conference call (announced in 8-K) ·
“I will start with an overview of our first quarter results and how the team is executing against our strategy, followed by updates on key clinical and product development initiatives.”
CEO, NeuroPace Inc Q1 FY2026 Earnings Call ·
“I want to start with what we always start with here is the mission of what we do here at Neuropace. And I do that because it really is what guides and catalyzes our activities and gives you a perspective as to the focus and the culture here of the business.”
CEO, 25th Annual Needham Virtual Healthcare Conference ·
“So, gentlemen, thank you all for joining. Thank you. Thanks, Mike. Thanks for having us. Thanks to Lear Inc. and looking forward to a great program today. Great.”
CEO, Leerink Global Healthcare Conference ·
“I will start with an overview of our fourth quarter results and how the team is executing against our strategy.”
CEO, NeuroPace Inc Q4 FY2025 Earnings Call ·

Affiliation history

  • NeuroPace Inc (NPCE)

    CEO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 21, 2026

  • NeuroPace Inc (NPCE)

    Board Member

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 21, 2026

Company network

Leadership on record at NeuroPace Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 NeuroPace Inc (NPCE) $567,567 $2,408,566
2024 NeuroPace Inc (NPCE) $528,667 $3,024,894
2023 NeuroPace Inc (NPCE) $248,333 $1,511,674

Recent activity